Considering that the heat shock system is activated in many cancer types, resulting in poor prognosis, and HSP90 may be considered a hub of the cross-interaction between metabolism and epigenetics, the metabolism–HSP90–epigenetics network highlighted in this review may represent a novel therapeutic target for successful cancer treatment. This evidence concerns the gene HSP90AB1 and cancer.